Eli Lilly and Company (TSX:LLY)
48.29
-0.38 (-0.78%)
Nov 6, 2026, 4:00 PM EST
Eli Lilly and Company Market Cap
Eli Lilly and Company has a market cap or net worth of CAD 1.7 trillion as of November 6, 2026. Its market cap has increased by 45.23% in one year.
Market Cap
1.70T
Enterprise Value
1.76T
Revenue
122.75B
Global Rank
n/a
Country Rank
n/a
PE Ratio
33.30
ChartMarket Cap Chart
Since July 9, 1970, Eli Lilly and Company's market cap has increased from 3.09B to 1.70T, an increase of 54,914.14%. That is a compound annual growth rate of 11.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 1.70T | 28.87% |
| Dec 31, 2025 | 1.32T | 31.91% |
| Dec 31, 2024 | 1.00T | 44.47% |
| Dec 29, 2023 | 692.31B | 47.15% |
| Dec 30, 2022 | 470.47B | 48.46% |
| Dec 31, 2021 | 316.90B | 62.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Apotex Health | 7.90B |
| Curaleaf Holdings | 3.51B |
| Extendicare | 2.62B |
| Sienna Senior Living | 2.28B |
| Green Thumb Industries | 2.08B |
| Cronos Group | 1.88B |
| Knight Therapeutics | 1.12B |
| WELL Health Technologies | 1.06B |